Skip to main content
OpenTrials

Clinical trial condition

Cystic Fibrosis

Explore clinical trials studying Cystic Fibrosis. Study availability and eligibility vary by location and protocol.

1,061 public trials 74 recruiting studies
Refine in advanced search Browse all conditions

Cystic Fibrosis trial results

Completed

A Prospective Study to Evaluate Biological and Clinical Effects of Significantly Corrected CFTR Function

NCT04038047

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Digestive System Diseases, +5 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Providence Alaska Medical Center Anchorage, Alaska, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Stanford University Medical Center Palo Alto, California, United States
View all 56 locations
View Trial Details
Completed

Cefiderocol Pharmacokinetics in Adult Patients With Cystic Fibrosis

NCT05314764

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +11 more
Locations
  • Hartford Hospital Hartford, Connecticut, United States
  • IU Health University Hospital Indianapolis, Indiana, United States
  • UPMC Presbyterian Hospital Pittsburgh, Pennsylvania, United States
  • UT Southwestern Clements University Hospital Dallas, Texas, United States
View Trial Details
Completed

Impact of Discontinuing Chronic Therapies in People With Cystic Fibrosis on Highly Effective CFTR Modulator Therapy

NCT04378153

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Digestive System Diseases, +5 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Providence Alaska Medical Center Anchorage, Alaska, United States
  • Tucson Cystic Fibrosis Center Tucson, Arizona, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
View all 80 locations
View Trial Details
Completed

Safety, Pharmacokinetic and Pharmacodynamic Study of MP-376 in Patients With Cystic Fibrosis

NCT00503490

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Digestive System Diseases, +5 more
Locations
  • La Jolla, California, United States
  • Los Angeles, California, United States
  • Palo Alto, California, United States
  • Orlando, Florida, United States
View all 14 locations
View Trial Details
Completed

NETwork of Linoleic Acid Supplementation in Cystic Fibrosis

NCT04531410

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Digestive System Diseases, +5 more
Locations
  • Università degli Studi di Milan Milan, Italy
  • Norwegian Resourse Center for Cystic Fibrosis, Oslo University Hospital Oslo, Norway
  • Poznan University of Medical Sciences Poznan, Poland
View Trial Details

Related conditions